{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T12:31:45Z","timestamp":1789648305017,"version":"4.0.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,11]],"date-time":"2020-01-11T00:00:00Z","timestamp":1578700800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,1,11]],"date-time":"2020-01-11T00:00:00Z","timestamp":1578700800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Bone mineral density of the humeral head is an independent determining factor for postoperative rotator cuff tendon healing. Bisphosphonates, which are commonly used to treat osteoporosis, have raised concerns regarding their relationships to osteonecrosis of the jaw and to atypical fracture of the femur. In view of the prevalence of rotator cuff tear in osteoporotic elderly people, it is important to determine whether bisphosphonates affect rotator cuff tendon healing. However, no studies have investigated bisphosphonates\u2019 cytotoxicity to human rotator cuff tendon fibroblasts (HRFs) or bisphosphonates\u2019 effects on rotator cuff tendon healing. The purpose of this study was to evaluate the cytotoxicity of alendronate (Ald), a bisphosphonate, and its effects on HRF wound healing.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>HRFs were obtained from human supraspinatus tendons, using primary cell cultures. The experimental groups were control, 0.1\u2009\u03bcM Ald, 1\u2009\u03bcM Ald, 10\u2009\u03bcM Ald, and 100\u2009\u03bcM Ald. Alendronate exposure was for 48\u2009h, except during a cell viability analysis with durations from 1\u2009day to 6\u2009days. The experimental groups were evaluated for cell viability, cell cycle and cell proliferation, type of cell death, caspase activity, and wound-healing ability.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>The following findings regarding the 100\u2009\u03bcM Ald group contrasted with those for all the other experimental groups: a significantly lower rate of live cells (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01), a higher rate of subG1 population, a lower rate of Ki-67 positive cells, higher rates of apoptosis and necrosis, a higher number of cells with DNA fragmentation, higher caspase-3\/7 activity (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), and a higher number of caspase-3 positive staining cells. In scratch-wound healing analyses of all the experimental groups, all the wounds healed within 48\u2009h, except in the 100\u2009\u03bcM Ald group (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Low concentrations of alendronate appear to have little effect on HRF viability, proliferation, migration, and wound healing. However, high concentrations are significantly cytotoxic, impairing cellular proliferation, cellular migration, and wound healing in vitro.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12891-019-3014-1","type":"journal-article","created":{"date-parts":[[2020,1,11]],"date-time":"2020-01-11T13:02:59Z","timestamp":1578747779000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["In vitro effects of alendronate on fibroblasts of the human rotator cuff tendon"],"prefix":"10.1186","volume":"21","author":[{"given":"Chang-Meen","family":"Sung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ra Jeong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Sool","family":"Hah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Yong","family":"Gwark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9468-6282","authenticated-orcid":false,"given":"Hyung Bin","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,11]]},"reference":[{"key":"3014_CR1","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1302\/0301-620X.91B2.21069","volume":"91","author":"S Moosmayer","year":"2009","unstructured":"Moosmayer S, Smith HJ, Tariq R, Larmo A. Prevalence and characteristics of asymptomatic tears of the rotator cuff: an ultrasonographic and clinical study. J Bone Joint Surg Br. 2009;91:196\u2013200.","journal-title":"J Bone Joint Surg Br"},{"key":"3014_CR2","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.2106\/JBJS.E.00835","volume":"88","author":"K Yamaguchi","year":"2006","unstructured":"Yamaguchi K, Ditsios K, Middleton WD, Hildebolt CF, Galatz LM, Teefey SA. The demographic and morphological features of rotator cuff disease. A comparison of asymptomatic and symptomatic shoulders. J Bone Joint Surg Am. 2006;88:1699\u2013704.","journal-title":"J Bone Joint Surg Am"},{"key":"3014_CR3","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1016\/j.jse.2014.08.001","volume":"23","author":"T Teunis","year":"2014","unstructured":"Teunis T, Lubberts B, Reilly BT, Ring D. A systematic review and pooled analysis of the prevalence of rotator cuff disease with increasing age. J Shoulder Elb Surg. 2014;23:1913\u201321.","journal-title":"J Shoulder Elb Surg"},{"key":"3014_CR4","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.1007\/s00198-014-2795-1","volume":"25","author":"JH Oh","year":"2014","unstructured":"Oh JH, Song BW, Kim SH, Choi JA, Lee JW, Chung SW, et al. The measurement of bone mineral density of bilateral proximal humeri using DXA in patients with unilateral rotator cuff tear. Osteoporos Int. 2014;25:2639\u201348.","journal-title":"Osteoporos Int"},{"key":"3014_CR5","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1177\/0363546509354989","volume":"38","author":"C Kirchhoff","year":"2010","unstructured":"Kirchhoff C, Braunstein V, Milz S, Sprecher CM, Fischer F, Tami A, et al. Assessment of bone quality within the tuberosities of the osteoporotic humeral head: relevance for anchor positioning in rotator cuff repair. Am J Sports Med. 2010;38:564\u20139.","journal-title":"Am J Sports Med"},{"key":"3014_CR6","doi-asserted-by":"publisher","first-page":"232596711773131","DOI":"10.1177\/2325967117731310","volume":"5","author":"AR Jensen","year":"2017","unstructured":"Jensen AR, Cha PS, Devana SK, Ishmael C, Di Pauli von Treuheim T, D'Oro A, et al. Evaluation of the trends, concomitant procedures, and complications with open and arthroscopic rotator cuff repairs in the Medicare population. Orthop J Sports Med. 2017;5:2325967117731310.","journal-title":"Orthop J Sports Med"},{"key":"3014_CR7","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.jse.2013.09.024","volume":"23","author":"JH Oh","year":"2014","unstructured":"Oh JH, Song BW, Lee YS. Measurement of volumetric bone mineral density in proximal humerus using quantitative computed tomography in patients with unilateral rotator cuff tear. J Shoulder Elb Surg. 2014;23:993\u20131002.","journal-title":"J Shoulder Elb Surg"},{"key":"3014_CR8","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.arthro.2015.08.034","volume":"32","author":"AE Hyatt","year":"2016","unstructured":"Hyatt AE, Lavery K, Mino C, Dhawan A. Suture anchor biomechanics after rotator cuff footprint decortication. Arthrosc. 2016;32:544\u201350.","journal-title":"Arthrosc"},{"key":"3014_CR9","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1177\/0363546511415659","volume":"39","author":"SW Chung","year":"2011","unstructured":"Chung SW, Oh JH, Gong HS, Kim JY, Kim SH. Factors affecting rotator cuff healing after arthroscopic repair: osteoporosis as one of the independent risk factors. Am J Sports Med. 2011;39:2099\u2013107.","journal-title":"Am J Sports Med"},{"key":"3014_CR10","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s40902-019-0210-8","volume":"41","author":"HJ Son","year":"2019","unstructured":"Son HJ, Kim JW, Kim SJ. Pharmacoepidemiology and clinical characteristics of medication-related osteonecrosis of the jaw. Maxillofac Plast Reconstr Surg. 2019;41:26.","journal-title":"Maxillofac Plast Reconstr Surg"},{"key":"3014_CR11","first-page":"13","volume":"38","author":"S Ishtiaq","year":"2014","unstructured":"Ishtiaq S, Fogelman I, Hampson G. Treatment of post-menopausal osteoporosis: beyond bisphosphonates. J Endocrinol. 2014;38:13\u201329.","journal-title":"J Endocrinol"},{"key":"3014_CR12","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1056\/NEJMc0910389","volume":"362","author":"CM Girgis","year":"2010","unstructured":"Girgis CM, Sher D, Seibel MJ. Atypical femoral fractures and bisphosphonate use. N Engl J Med. 2010;362:1848\u20139.","journal-title":"N Engl J Med"},{"key":"3014_CR13","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1007\/s00198-008-0805-x","volume":"20","author":"BA Lenart","year":"2009","unstructured":"Lenart BA, Neviaser AS, Lyman S, Chang CC, Edobor-Osula F, Steele B, et al. Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study. Osteoporos Int. 2009;20:1353\u201362.","journal-title":"Osteoporos Int"},{"key":"3014_CR14","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1111\/odi.12154","volume":"20","author":"E Donetti","year":"2014","unstructured":"Donetti E, Gualerzi A, Sardella A, Lodi G, Carrassi A, Sforza C. Alendronate impairs epithelial adhesion, differentiation and proliferation in human oral mucosa. Oral Dis. 2014;20:466\u201372.","journal-title":"Oral Dis"},{"key":"3014_CR15","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1177\/0960327115569808","volume":"34","author":"SS Soydan","year":"2015","unstructured":"Soydan SS, Araz K, Senel FV, Yurtcu E, Helvacioglu F, Dagdeviren A, et al. Effects of alendronate and pamidronate on apoptosis and cell proliferation in cultured primary human gingival fibroblasts. Hum Exp Toxicol. 2015;34:1073\u201382.","journal-title":"Hum Exp Toxicol"},{"key":"3014_CR16","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.joen.2014.07.010","volume":"41","author":"CA Martins","year":"2015","unstructured":"Martins CA, Leyhausen G, Volk J, Geurtsen W. Effects of alendronate on osteoclast formation and activity in vitro. J Endod. 2015;41:45\u20139.","journal-title":"J Endod"},{"key":"3014_CR17","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/jcmm.12154","volume":"18","author":"V Ribeiro","year":"2014","unstructured":"Ribeiro V, Garcia M, Oliveira R, Gomes PS, Colaco B, Fernandes MH. Bisphosphonates induce the osteogenic gene expression in co-cultured human endothelial and mesenchymal stem cells. J Cell Mol Med. 2014;18:27\u201337.","journal-title":"J Cell Mol Med"},{"key":"3014_CR18","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/j.1600-9657.2005.00434.x","volume":"22","author":"F Correia Vde","year":"2006","unstructured":"Correia Vde F, Caldeira CL, Marques MM. Cytotoxicity evaluation of sodium alendronate on cultured human periodontal ligament fibroblasts. Dent Traumatol. 2006;22:312\u20137.","journal-title":"Dent Traumatol"},{"key":"3014_CR19","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1111\/j.1745-7254.2007.00607.x","volume":"28","author":"TJ Lai","year":"2007","unstructured":"Lai TJ, Hsu SF, Li TM, Hsu HC, Lin JG, Hsu CJ, et al. Alendronate inhibits cell invasion and MMP-2 secretion in human chondrosarcoma cell line. Acta Pharmacol Sin. 2007;28:1231\u20135.","journal-title":"Acta Pharmacol Sin"},{"key":"3014_CR20","doi-asserted-by":"publisher","first-page":"6332","DOI":"10.1038\/ncomms7332","volume":"6","author":"M Ueno","year":"2015","unstructured":"Ueno M, Maeno T, Nishimura S, Ogata F, Masubuchi H, Hara K, et al. Alendronate inhalation ameliorates elastase-induced pulmonary emphysema in mice by induction of apoptosis of alveolar macrophages. Nat Commun. 2015;6:6332.","journal-title":"Nat Commun"},{"key":"3014_CR21","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1600-0765.2010.01306.x","volume":"46","author":"DA Tipton","year":"2011","unstructured":"Tipton DA, Seshul BA, Dabbous M. Effect of bisphosphonates on human gingival fibroblast production of mediators of osteoclastogenesis: RANKL, osteoprotegerin and interleukin-6. J Periodontal Res. 2011;46:39\u201347.","journal-title":"J Periodontal Res"},{"key":"3014_CR22","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1111\/j.1600-9657.2005.00370.x","volume":"21","author":"MS Moreira","year":"2005","unstructured":"Moreira MS, Katayama E, Bombana AC, Marques MM. Cytotoxicity analysis of alendronate on cultured endothelial cells and subcutaneous tissue. A pilot study. Dent Traumatol. 2005;21:329\u201335.","journal-title":"Dent Traumatol"},{"key":"3014_CR23","doi-asserted-by":"publisher","first-page":"e105705","DOI":"10.1371\/journal.pone.0105705","volume":"9","author":"CH Chang","year":"2014","unstructured":"Chang CH, Wang CZ, Chang JK, Hsu CY, Ho ML. The susceptive alendronate-treatment timing and dosage for osteogenesis enhancement in human bone marrow-derived stem cells. PLoS One. 2014;9:e105705.","journal-title":"PLoS One"},{"key":"3014_CR24","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9","volume":"182","author":"T Scholzen","year":"2000","unstructured":"Scholzen T, Gerdes J. The Ki-67 protein: from the known and the unknown. Scholzen T, Gerdes J. the Ki-67 protein: from the known and the unknown. J Cell Physiol. 2000;182:311\u201322.","journal-title":"J Cell Physiol"},{"key":"3014_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4939-1661-0_1","volume":"1219","author":"GS Choudhary","year":"2015","unstructured":"Choudhary GS, Al-Harbi S, Almasan A. Caspase-3 activation is a critical determinant of genotoxic stress-induced apoptosis. Methods Mol Biol. 2015;1219:1\u20139.","journal-title":"Methods Mol Biol"},{"key":"3014_CR26","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.immuni.2016.01.020","volume":"44","author":"L Galluzzi","year":"2016","unstructured":"Galluzzi L, Lopez-Soto A, Kumar S, Kroemer G. Caspases connect cell-death signaling to organismal homeostasis. Immun. 2016;44:221\u201331.","journal-title":"Immun"},{"key":"3014_CR27","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/imr.12541","volume":"277","author":"B Tummers","year":"2017","unstructured":"Tummers B, Green DR. Caspase-8: regulating life and death. Immunol Rev. 2017;277:76\u201389.","journal-title":"Immunol Rev"},{"key":"3014_CR28","doi-asserted-by":"publisher","first-page":"3179","DOI":"10.1101\/gad.13.24.3179","volume":"13","author":"J Rodriguez","year":"1999","unstructured":"Rodriguez J, Lazebnik Y. Caspase-9 and APAF-1 form an active holoenzyme. Genes Dev. 1999;13:3179\u201384.","journal-title":"Genes Dev"},{"key":"3014_CR29","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1007\/s10620-007-9769-5","volume":"52","author":"K Amagase","year":"2007","unstructured":"Amagase K, Hayashi S, Nishikawa K, Aihara E, Takeuchi K. Impairment of gastric ulcer healing by alendronate, a nitrogen-containing bisphosphonate, in rats. Dig Dis Sci. 2007;52:1879\u201389.","journal-title":"Dig Dis Sci"},{"key":"3014_CR30","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/jor.20293","volume":"25","author":"S Thomopoulos","year":"2007","unstructured":"Thomopoulos S, Matsuzaki H, Zaegel M, Gelberman RH, Silva MJ. Alendronate prevents bone loss and improves tendon-to-bone repair strength in a canine model. J Orthop Res. 2007;25:473\u20139.","journal-title":"J Orthop Res"},{"key":"3014_CR31","doi-asserted-by":"publisher","first-page":"78","DOI":"10.22203\/eCM.v025a06","volume":"25","author":"PP Lui","year":"2013","unstructured":"Lui PP, Lee YW, Mok TY, Cheuk YC, Chan KM. Alendronate reduced peri-tunnel bone loss and enhanced tendon graft to bone tunnel healing in anterior cruciate ligament reconstruction. Eur Cell Mater. 2013;25:78\u201396.","journal-title":"Eur Cell Mater"},{"key":"3014_CR32","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1080\/17453674.2018.1440189","volume":"89","author":"GA Hjorthaug","year":"2018","unstructured":"Hjorthaug GA, Soreide E, Nordsletten L, Madsen JE, Reinholt FP, Niratisairak S, et al. Negative effect of zoledronic acid on tendon-to-bone healing. Acta Orthop. 2018;89:360\u20136.","journal-title":"Acta Orthop"},{"key":"3014_CR33","doi-asserted-by":"publisher","first-page":"e2014","DOI":"10.1097\/MD.0000000000002014","volume":"94","author":"J Liu","year":"2015","unstructured":"Liu J, Huang W, Zhou R, Jia S, Tang W, Luo Y, et al. Bisphosphonates in the treatment of patients with metastatic breast, lung, and prostate Cancer: a meta-analysis. Medicine (Baltimore). 2015;94:e2014.","journal-title":"Medicine (Baltimore)"},{"key":"3014_CR34","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1345\/aph.1E357","volume":"39","author":"AA Licata","year":"2005","unstructured":"Licata AA. Discovery, clinical development, and therapeutic uses of bisphosphonates. Ann Pharmacother. 2005;39:668\u201377.","journal-title":"Ann Pharmacother"},{"key":"3014_CR35","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.14219\/jada.archive.2005.0108","volume":"136","author":"CA Migliorati","year":"2005","unstructured":"Migliorati CA, Casiglia J, Epstein J, Jacobsen PL, Siegel MA, Woo SB. Managing the care of patients with bisphosphonate-associated osteonecrosis: an American Academy of Oral medicine position paper. J Am Dent Assoc. 2005;136:1658\u201368.","journal-title":"J Am Dent Assoc"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-019-3014-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12891-019-3014-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-019-3014-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,10]],"date-time":"2021-01-10T00:18:44Z","timestamp":1610237924000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-019-3014-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,11]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["3014"],"URL":"https:\/\/doi.org\/10.1186\/s12891-019-3014-1","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,11]]},"assertion":[{"value":"8 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was carried out in accordance with the permission of the Gyeongsang National University Institutional Review Board (GNUHIRB-2009-022) in the Gyeongsang National University Hospital. All participants signed an informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflicts of interest with the contents of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19"}}